Acurx Pharmaceuticals, Inc.
ACXPNasdaqCIK 1736243HealthcareFiscal year ends Dec 31
Reports and events: 84 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-118064 |
| 2023-11-1316:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018824 |
| 2023-11-0316:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-114274 |
| 2023-10-0216:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-105928 |
| 2023-08-1407:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-090878 |
| 2023-08-1116:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014645 |
| 2023-06-2916:07 ET | S-1 | Registration statement | 0001104659-23-076317 |
| 2023-06-2016:44 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-072936 |
| 2023-05-1716:19 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001104659-23-061848 |
| 2023-05-1207:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-009495 |
| 2023-04-2716:11 ET | DEF 14A | Proxy statementPeriod 2023-06-15 | 0001104659-23-051339 |
| 2023-03-1607:22 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-033054 |
| 2023-03-1517:25 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-003929 |
| 2022-11-1407:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-117682 |
| 2022-11-1016:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-017408 |
| 2022-09-1416:06 ET | S-1 | Registration statement | 0001104659-22-100019 |
| 2022-08-1516:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-091225 |
| 2022-08-1216:07 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001410578-22-002396 |
| 2022-07-2508:46 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-22-082266 |
| 2022-06-0716:10 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-068951 |
| 2022-05-1107:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-058543 |
| 2022-05-1016:07 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001410578-22-001250 |
| 2022-04-2516:06 ET | DEF 14A | Proxy statementPeriod 2022-06-07 | 0001104659-22-049621 |
| 2022-03-1707:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-034747 |
| 2022-03-1616:05 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001410578-22-000399 |
| 2021-11-1606:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-139573 |
| 2021-11-1216:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001104659-21-138038 |
| 2021-08-1616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-106315 |
| 2021-08-1316:06 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001104659-21-105074 |
| 2021-07-0616:21 ET | SC 13D | Ownership report, active investor | 0001104659-21-089430 |
| 2021-07-0616:20 ET | SC 13D | Ownership report, active investor | 0001104659-21-089429 |
| 2021-06-2917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-086902 |
| 2021-06-1106:02 ET | S-1/A | Registration statement, amended | 0001104659-21-079723 |
| 2021-05-2718:14 ET | S-1 | Registration statement | 0001104659-21-072553 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:17 ET. Listed shows no prices and gives no investment advice.